Global Point-of-care Molecular Diagnostics Market Size & Outlook
Global point-of-care molecular diagnostics market, 2021-2033 (US$M)
Related Markets
Global point-of-care molecular diagnostics market highlights
- The global point-of-care molecular diagnostics market generated a revenue of USD 8,219.3 million in 2024 and is expected to reach USD 14,468.1 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 6.5% by 2033.
- In terms of segment, infectious diseases accounted for a revenue of USD 4,099.2 million in 2024.
- Oncology is the most lucrative application segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 8,219.3 million |
| Market revenue in 2033 | USD 14,468.1 million |
| Growth rate | 6.5% (CAGR from 2025 to 2033) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Oncology |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
Other key industry trends
- In terms of revenue, the North America accounted for 45.7% of the global point-of-care molecular diagnostics market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, UK is the fastest growing regional market and is projected to reach USD 394.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Point-of-Care Molecular Diagnostics Market Scope
Point-of-Care Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abaxis | View profile | 5001-10000 | Union City, California, United States, North America | http://abaxis.com |
| OraSure Technologies Inc | View profile | 638 | 220 East First Street, Bethlehem, PA, United States, 18015 | https://www.orasure.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Nipro Corp | View profile | 39713 | 3-9-3 Honjo-Nishi Kita-ku, Osaka, Japan, 531-8510 | http://www.nipro.co.jp |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Nova Biomedical | View profile | 501-1000 | Waltham, Massachusetts, United States, North America | http://www.novabio.us |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Global point-of-care molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 49.87% in 2024. Horizon Databook has segmented the Global point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Point-of-Care Molecular Diagnostics Application Outlook (Revenue, USD Million, 2021-2033)
- Oncology
- Prenatal Testing
- Endocrinology
- Other Applications
- Hematology
- Complete blood count (CBC)
- Prothrombin time (PT)
- Partial Thromboplastin Time (PTT)
- Others
- Infectious Diseases
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus associated infections
- Respiratory syncytial virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and drug-resistant TB POC
- HSV POC
- Other Infectious Diseases
- Global Point-of-Care Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2021-2033)
- PCR-based
- Genetic Sequencing based
- Hybridization based
- Microarray based
- Global Point-of-Care Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2021-2033)
- OTC
- POC
- Global Point-of-Care Molecular Diagnostics End Use Outlook (Revenue, USD Million, 2021-2033)
- Decentralised Labs
- Hospitals
- Home care
- Assisted Living Healthcare Facilities
- Others
Reasons to subscribe to Global point-of-care molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global point-of-care molecular diagnostics market databook
-
Our clientele includes a mix of point-of-care molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global point-of-care molecular diagnostics market , including forecasts for subscribers. This global databook contains high-level insights into Global point-of-care molecular diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global point-of-care molecular diagnostics market size, by regions, 2021-2033 (US$M)
Top 10 countries: Point-of-care molecular diagnostics market size, 2024 (US$M)
Global point-of-care molecular diagnostics market share, by application, 2024 & 2033 (%, US$M)
Point-of-care molecular diagnostics market: Opportunity assessment by country
Global point-of-care molecular diagnostics market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
